Business Wire

Wipro Hydraulics Signs Definitive Agreement With Indeco to Expand Product Offerings

16.4.2026 13:31:00 CEST | Business Wire | Press Release

Share

Wipro Hydraulics and Indeco Ind Spa are proud to announce that they have entered into a definitive agreement for Wipro to acquire Indeco Ind Spa. This landmark partnership comes at a symbolic moment, as both companies celebrate 50 years of engineering excellence and market leadership.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260416708709/en/

ndeco manufacturing facility in Bari, Italy

The union brings together two leaders in their respective fields: Indeco, a global benchmark in hydraulic attachments, and Wipro Hydraulics, one of the world’s largest independent manufacturers of hydraulic cylinders. This strategic move will provide the global reach and industrial strength required to make us even greater while preserving the identity that has defined the brand for half a century.

Commenting on the acquisition, Mr. Pratik Kumar, CEO, Wipro Infrastructure Engineering (WIN) & Managing Director, Wipro Enterprises, said:"This acquisition marks a milestone for us and an entry into a new adjacent space for our hydraulics business.It fulfils our quest for growth while expanding opportunities to serve our customers better.”

Mr. Sitaram Ganeshan, President, Wipro Hydraulics, said:"This acquisition adds attachments to our current hydraulic cylinder portfolio thereby broadening our customer offering. Our value proposition is enhanced with the expanded manufacturing & distribution footprint and talent. Wipro Hydraulics and Indeco each brings a 50-year legacy, with strong product positioning built on innovation, quality, reliability, and customer service."

Ms. Susanna Vitulano, CEO of Indeco Ind Spa, commented:"It has been a privilege to be part of this incredible journey as we built Indeco into a respected global brand. Today, our products are synonymous with reliability and superior service. Wipro is the perfect partner to nurture our next phase of growth. Indeco will leverage enhanced R&D capabilities and a vast global network to further develop its existing organisation and products.”

“The Vitulano family remains deeply committed to this partnership, staying fully and operationally involved in Indeco. This ensures that the passion and values that built Indeco will continue to help us flourish within the Wipro Group."

This partnership was facilitated by PwC as Wipro’s financial advisor, with A&O Shearman serving as legal advisors. On Indeco’s side, BNP Paribas and KT&Partners acted as financial advisors with PedersoliGattai acting as legal advisors.

About Wipro Infrastructure Engineering

Wipro Infrastructure Engineering, a part of Wipro Enterprises, is a diversified business with expertise spanning five decades of engineering and manufacturing excellence in Hydraulics, Industrial Automation, Aerospace, Water Treatment, Additive Manufacturing and Electronic Materials. Wipro Hydraulics specializes in designing and manufacturing custom-built Hydraulic Cylinders for applications in diverse segments such as Construction & Earthmoving, Material & Cargo Handling, Forestry, Farm & Agriculture, Mining, and Truck Tipping Solutions. Wipro Hydraulics operates 16 manufacturing facilities globally.

For more information visit www.wiproinfra.com.

About Indeco Ind Spa

Indeco Ind Spa, established in 1976, is an Italy based company focused on Attachments in Construction, Demolition and Recycling industries. Key products are Hydraulic Hammers, Mulching Heads, Shears & a variety of other demolition-related attachments. They have 7 manufacturing facilities in Italy for production of Hydraulic Hammers and a plant in the US for manufacturing Mulching Heads. Their innovative products combined with global distribution network offers an attractive value proposition for the industry.

For more information visit https://indeco.it/en/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260416708709/en/

Contacts

Contact for more information: Sahifa Mehta: sahifa.mehta@wipro.com +91 98 99 111
209

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press Release

HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l

BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubrutinib) plus next-generation BCL2 inhibitor BEQALZI™ (sonrotoclax; ZS), which continue to demonstrate rapid, deep, durable responses across multiple B-cell malignancies. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “BTK inhibition has reshaped the treatment of B-cell cancers, and we believe degradation is the next leap forwa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye